European Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Household Out-of-Pocket Payment Share by Country (Million Euros)

The analysis of European healthcare expenditure on pharmaceuticals and medical non-durable goods by household out-of-pocket payments reveals varying values across countries in 2023, with the United Kingdom and Germany leading and countries like Liechtenstein and Luxembourg at the low end. Year-on-year, substantial variations exist, notably in Romania with an increase of 11.68%, whereas France experienced a slight decline of 0.34%. Notable CAGR trends over the past five years include rising costs in Spain and Austria, with significant growth in household contributions.

Future trends to watch include the implications of rising pharmaceutical costs due to inflation, enhanced healthcare access, and demographic shifts like the aging population. Monitoring regulatory changes and pharmaceutical innovation in legislation can also critically impact household spending patterns.